Despite the successful use of antibiotics and hormones in rheumatism, many unresolved issues remain in the treatment of rheumatism. Further progress in this regard largely depends on the development of such therapeutic tactics that would correspond to the dynamics of pathological reactions in rheumatism.
The defeat of the connective tissue in collagen diseases is, as is known, in the destruction of the collagen complex with pathological release of proteins, polysaccharides, mucoproteins into the blood.
As shown by numerous studies of A.E.Braunstein with colleagues and many other authors, the violation of tryptophan metabolism is the result of a deficiency in the body of vitamin B6.
In this work, we proceeded from the generally accepted view of the etiological role of group A hemolytic streptococcus in the development of the pathological process in rheumatism.
There is no complete consensus on the issue of preventive treatment for rheumatics.
Recently, works began to appear in the literature on elucidating the role of protein-carbohydrate complexes - glucoproteins (mucoproteins) in atherosclerosis.